Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (728) Wet Lab Protocols and Methods (8) Bioinformatics Methods and Algorithms (18) Cancer genomic data analysis (12) Chemotherapy and Side Effects Management (120) Methods in Cancer Research (59)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/79865, first published .
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study

Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study

Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study

Authors of this article:

Swetambri Sharma1 Author Orcid Image ;   Shuvadeep Ganguly2 Author Orcid Image ;   Kamali Murugadoss2 Author Orcid Image ;   Smita Kayal2 Author Orcid Image ;   Swaminathan Keerthivasagam2 Author Orcid Image ;   Jaikumar Ramamoorthy3 ;   Archna Singh4 Author Orcid Image ;   Deepam Pushpam1 Author Orcid Image ;   Jayanthi Mathaiyan5 Author Orcid Image ;   Yvonne Gloor6 Author Orcid Image ;   Frederic Baleydier6 Author Orcid Image ;   Marc Ansari6 Author Orcid Image ;   Sameer Bakhshi1 Author Orcid Image ;   Biswajit Dubashi2 Author Orcid Image ;   Chakradhara Rao S Uppugunduri2, 6 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

There are no citations yet available for this article according to Crossref .